NO20031095L - Farmasoytiske sammensetninger - Google Patents

Farmasoytiske sammensetninger

Info

Publication number: NO20031095L
Authority: NO; Norway
Prior art keywords: pharmaceutical compositions; pharmaceutical; compositions
Prior art date: 2000-09-11

Application number

NO20031095A

Other languages

English (en)

Other versions

NO20031095D0 (no

Inventor

Simon David Bateman

Alberto Gimona

Jurij Holinej

Jasper Huels

Sumedha Jayawardene

Argeris Jerry Karabelas

Maha Y Khaled

Anees Abdulguadar Karnachi

Eimear Mairin Nic Lochlainn

Richard Macerata

Victor Sloan

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-09-11

Filing date

2003-03-10

Publication date

2003-03-10

2003-03-10 Application filed by Novartis Ag filed Critical Novartis Ag

2003-03-10 Publication of NO20031095L publication Critical patent/NO20031095L/no

2003-03-10 Publication of NO20031095D0 publication Critical patent/NO20031095D0/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Rheumatology (AREA)
Endocrinology (AREA)
Pain & Pain Management (AREA)
Immunology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Diabetes (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

NO20031095A 2000-09-11 2003-03-10 Farmasöytiske sammensetninger NO20031095D0 (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US23165500P	2000-09-11	2000-09-11
US23226100P	2000-09-14	2000-09-14
PCT/EP2001/010448 WO2002020090A2 (en)	2000-09-11	2001-09-10	Pharmaceutical compositions

Publications (2)

Publication Number	Publication Date
NO20031095L true NO20031095L (no)	2003-03-10
NO20031095D0 NO20031095D0 (no)	2003-03-10

Family

ID=26925315

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20031095A NO20031095D0 (no)	2000-09-11	2003-03-10	Farmasöytiske sammensetninger

Country Status (28)

Country	Link
US (2)	US20020061932A1 (no)
EP (1)	EP1331972B1 (no)
JP (2)	JP2004527458A (no)
KR (1)	KR20030036730A (no)
CN (1)	CN100490797C (no)
AR (1)	AR030630A1 (no)
AT (1)	ATE366128T1 (no)
AU (2)	AU1390002A (no)
BR (1)	BR0113809A (no)
CA (1)	CA2416771C (no)
CY (1)	CY1107729T1 (no)
CZ (1)	CZ2003673A3 (no)
DE (1)	DE60129238T2 (no)
DK (1)	DK1331972T3 (no)
ES (1)	ES2290181T3 (no)
HU (1)	HUP0301128A3 (no)
IL (2)	IL154238A0 (no)
MX (1)	MXPA03002105A (no)
MY (1)	MY126117A (no)
NO (1)	NO20031095D0 (no)
NZ (1)	NZ524785A (no)
PE (1)	PE20020351A1 (no)
PL (1)	PL359721A1 (no)
PT (1)	PT1331972E (no)
RU (1)	RU2316324C2 (no)
SI (1)	SI1331972T1 (no)
SK (1)	SK2902003A3 (no)
WO (1)	WO2002020090A2 (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20030114527A1 (en) *	2001-08-31	2003-06-19	Karnachi Anees Abdulquadar	Pharmaceutical composition
GB0201520D0 (en) *	2002-01-23	2002-03-13	Novartis Ag	Pharmaceutical uses
PL370907A1 (en) *	2002-03-07	2005-05-30	Novartis Ag	Pharmaceutical compositions
CA2487414A1 (en)	2002-06-11	2003-12-18	Nitromed, Inc.	Nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use
PE20040844A1 (es)	2002-11-26	2004-12-30	Novartis Ag	Acidos fenilaceticos y derivados como inhibidores de la cox-2
TWI327913B (en) *	2003-03-12	2010-08-01	Novartis Ag	Pharmaceutical composition comprising 5-methyl-2-(2'-chloro-6'-fluoroanilino)phenylacetic acid
US20050131028A1 (en) *	2003-09-11	2005-06-16	Pharmacia Corporation	Methods and compositions for the extended duration treatment of pain, inflammation and inflammation-related disorders
RU2423979C2 (ru) *	2005-06-17	2011-07-20	АФТ Фармасьютикалз Лимитед	Новая фармацевтическая композиция и ее применение в способе лечения пациентов с гиперемией и отеком слизистой оболочки верхних дыхательных путей
FR2898492B1 (fr) *	2006-03-15	2008-06-06	Pierre Fabre Medicament Sa	Comprimes orodispersibles de domperidone
EP2043613A1 (en) *	2006-07-14	2009-04-08	Fmc Corporation	Solid form
WO2008086530A2 (en) *	2007-01-11	2008-07-17	Analog Devices, Inc.	Mems sensor with cap electrode
CA2735677A1 (en) *	2008-08-22	2010-02-25	Novartis Ag	Use of a cox-2 inhibitor for the treatment of a cox-2 dependent disorder in a patient not carrying hla alleles associated with hepatotoxicity
US8227451B2 (en)	2008-11-12	2012-07-24	Auspex Pharmaceuticals	Phenylacetic acid inhibitors of cyclooxygenase
CN103773596B (zh) *	2013-12-31	2016-05-18	上海复力生物医药科技有限公司	磷虾油的制备方法
WO2018049008A1 (en)	2016-09-07	2018-03-15	Trustees Of Tufts College	Dash inhibitors, and uses related thereto
KR20200058496A (ko)	2017-09-26	2020-05-27	테사로, 인코포레이티드	니라파립 제제

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH08511009A (ja) *	1993-06-08	1996-11-19	チバ−ガイギーアクチェンゲゼルシャフト	ジクロフェナックを含有する経口固体剤形の製造方法
US5474995A (en) *	1993-06-24	1995-12-12	Merck Frosst Canada, Inc.	Phenyl heterocycles as cox-2 inhibitors
IL126899A (en) *	1996-05-17	2004-03-28	Merck & Co Inc	Preparations for once-daily treatment of diseases mediated by cyclooxygenase-2
CO4960662A1 (es) *	1997-08-28	2000-09-25	Novartis Ag	Ciertos acidos 5-alquil-2-arilaminofenilaceticos y sus derivados
SA99191255B1 (ar) *	1998-11-30	2006-11-25	جي دي سيرل اند كو	مركبات سيليكوكسيب celecoxib
US20030114527A1 (en) *	2001-08-31	2003-06-19	Karnachi Anees Abdulquadar	Pharmaceutical composition

2001
- 2001-09-07 AR ARP010104260A patent/AR030630A1/es unknown
- 2001-09-07 PE PE2001000900A patent/PE20020351A1/es not_active Application Discontinuation
- 2001-09-10 NZ NZ524785A patent/NZ524785A/en unknown
- 2001-09-10 MY MYPI20014237A patent/MY126117A/en unknown
- 2001-09-10 CZ CZ2003673A patent/CZ2003673A3/cs unknown
- 2001-09-10 DK DK01982270T patent/DK1331972T3/da active
- 2001-09-10 CN CNB018154549A patent/CN100490797C/zh not_active Expired - Fee Related
- 2001-09-10 JP JP2002524572A patent/JP2004527458A/ja not_active Withdrawn
- 2001-09-10 RU RU2003109606/15A patent/RU2316324C2/ru not_active IP Right Cessation
- 2001-09-10 SI SI200130773T patent/SI1331972T1/sl unknown
- 2001-09-10 EP EP01982270A patent/EP1331972B1/en not_active Expired - Lifetime
- 2001-09-10 KR KR10-2003-7002711A patent/KR20030036730A/ko not_active Ceased
- 2001-09-10 AT AT01982270T patent/ATE366128T1/de active
- 2001-09-10 DE DE60129238T patent/DE60129238T2/de not_active Expired - Lifetime
- 2001-09-10 CA CA2416771A patent/CA2416771C/en not_active Expired - Fee Related
- 2001-09-10 AU AU1390002A patent/AU1390002A/xx active Pending
- 2001-09-10 PT PT01982270T patent/PT1331972E/pt unknown
- 2001-09-10 WO PCT/EP2001/010448 patent/WO2002020090A2/en not_active Ceased
- 2001-09-10 IL IL15423801A patent/IL154238A0/xx active IP Right Grant
- 2001-09-10 HU HU0301128A patent/HUP0301128A3/hu unknown
- 2001-09-10 SK SK290-2003A patent/SK2902003A3/sk unknown
- 2001-09-10 ES ES01982270T patent/ES2290181T3/es not_active Expired - Lifetime
- 2001-09-10 AU AU2002213900A patent/AU2002213900C1/en not_active Ceased
- 2001-09-10 PL PL35972101A patent/PL359721A1/xx not_active Application Discontinuation
- 2001-09-10 MX MXPA03002105A patent/MXPA03002105A/es active IP Right Grant
- 2001-09-10 BR BR0113809-0A patent/BR0113809A/pt not_active Application Discontinuation
- 2001-09-11 US US09/950,538 patent/US20020061932A1/en not_active Abandoned
2003
- 2003-01-30 IL IL154238A patent/IL154238A/en not_active IP Right Cessation
- 2003-03-10 NO NO20031095A patent/NO20031095D0/no not_active Application Discontinuation
2004
- 2004-03-24 US US10/807,734 patent/US20040186179A1/en not_active Abandoned
2007
- 2007-09-07 CY CY20071101157T patent/CY1107729T1/el unknown
2011
- 2011-03-09 JP JP2011051754A patent/JP2011144194A/ja active Pending

Also Published As

Publication number	Publication date
PL359721A1 (en)	2004-09-06
ATE366128T1 (de)	2007-07-15
BR0113809A (pt)	2003-07-29
AR030630A1 (es)	2003-08-27
CN1455691A (zh)	2003-11-12
HUP0301128A2 (hu)	2003-10-28
IL154238A (en)	2008-11-26
JP2004527458A (ja)	2004-09-09
PT1331972E (pt)	2007-10-16
NZ524785A (en)	2005-10-28
WO2002020090A3 (en)	2003-05-30
AU1390002A (en)	2002-03-22
RU2316324C2 (ru)	2008-02-10
EP1331972B1 (en)	2007-07-04
EP1331972A2 (en)	2003-08-06
DK1331972T3 (da)	2007-11-05
WO2002020090A2 (en)	2002-03-14
KR20030036730A (ko)	2003-05-09
HUP0301128A3 (en)	2005-04-28
SI1331972T1 (sl)	2007-12-31
MY126117A (en)	2006-09-29
CA2416771C (en)	2010-11-02
US20020061932A1 (en)	2002-05-23
CA2416771A1 (en)	2002-03-14
CZ2003673A3 (cs)	2003-06-18
NO20031095D0 (no)	2003-03-10
MXPA03002105A (es)	2003-06-19
DE60129238T2 (de)	2008-03-06
IL154238A0 (en)	2003-09-17
ES2290181T3 (es)	2008-02-16
CN100490797C (zh)	2009-05-27
DE60129238D1 (de)	2007-08-16
US20040186179A1 (en)	2004-09-23
JP2011144194A (ja)	2011-07-28
SK2902003A3 (en)	2003-10-07
AU2002213900C1 (en)	2006-07-27
CY1107729T1 (el)	2013-04-18
AU2002213900B2 (en)	2006-02-16
PE20020351A1 (es)	2002-06-14
WO2002020090A9 (en)	2003-10-30

Publication	Publication Date	Title
AR028204A1 (es)	2003-04-30	Composiciones farmaceuticas electrohiladas
FI20105657L (fi)	2010-06-10	Farmaseuttisia koostumuksia
ITMI20010748A0 (it)	2001-04-06	Composizioni farmaceutiche
DK1524266T3 (da)	2007-06-25	Farmaceutisk sammensætning
FI20011478L (fi)	2003-01-06	Farmaseuttinen koostumus
NO20025450L (no)	2002-11-14	Ny farmasöytisk sammensetning
ATE303787T1 (de)	2005-09-15	Schergelzusammensetzungen
ITTO20010008A0 (it)	2001-01-10	Formulazione farmaceutica
PT1242087E (pt)	2004-06-30	Composicoes farmaceuticas
AR028197A1 (es)	2003-04-30	Composiciones antitranspirantes
NO20033556L (no)	2003-10-09	Farmasöytiske formuleringer
AT7729U3 (de)	2006-01-15	Pharmazeutische zusammensetzungen enthaltend amlodipinmaleat
EE05020B1 (et)	2008-06-16	Glburiidi ravimkoostis
EE200300589A (et)	2004-02-16	Ravimkoostised
NO20026123L (no)	2003-02-18	Farmasöytiske sammensetninger
ATE369830T1 (de)	2007-09-15	Schweisshemmende zusammensetzungen
ATE314049T1 (de)	2006-01-15	Schweisshemmende zusammensetzungen
FI20022128A0 (fi)	2002-12-03	Farmaseuttinen koostumus
NO20031095L (no)	2003-03-10	Farmasoytiske sammensetninger
PT1239832E (pt)	2004-10-29	Composicoes farmaceuticas
DE60116858D1 (de)	2006-04-13	Zusammensetzung
MXPA03001857A (es)	2003-06-04	Composicones medicinales.
EE200200689A (et)	2004-06-15	Ravimkoostised
DE60135223D1 (de)	2008-09-18	Shampoozusammensetzungen
EP1413314A4 (en)	2004-12-22	MEDICAL COMPOSITIONS

Legal Events

Date	Code	Title	Description
2011-04-26	FC2A	Withdrawal, rejection or dismissal of laid open patent application